Company profile for GO Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Multimodal first-in-class cancer therapeutics against intractable targets. The generation of solid tumor targeting domains specific to cancer cells remains a significant challenge in the biopharmaceutical industry. GO Therapeutics’ targeting platforms and technologies hold the promise to unlock the full potential of antibody-drug conjugates, bi-specific T-cell engagers, and immune-based cell therapies. GO Therapeutics is dev...
Multimodal first-in-class cancer therapeutics against intractable targets. The generation of solid tumor targeting domains specific to cancer cells remains a significant challenge in the biopharmaceutical industry. GO Therapeutics’ targeting platforms and technologies hold the promise to unlock the full potential of antibody-drug conjugates, bi-specific T-cell engagers, and immune-based cell therapies. GO Therapeutics is developing a range of cancer drug candidates that are exquisitely tumor specific.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One Broadway, Cambridge, MA 02142
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/go-astellas-picks-partner-convertiblecar-backloaded-780m-antibody-project

N.P. Taylor FIERCEBIOTECH
02 Jun 2022

https://www.prnewswire.com/news-releases/astellas-and-go-therapeutics-enter-into-strategic-research-and-license-agreement-to-develop-novel-antibodies-for-immuno-oncology-301558512.html

PRNEWSWIRE
31 May 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty